Rockefeller Capital Management L.P. Onconova Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.46 - $2.82 $584 - $1,128	-400 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$3.81 - $6.76 $632 - $1,122	-166 Reduced 29.33%	400 $1,000
Q2 2021 Aug 10, 2021	BUY	$6.28 - $16.2 $3,554 - $9,169	566 New	566 $3,000

249K

Ticker ONTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,895,600
Market Cap $12.3M
Description
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.